Explore a wide range of affordable, high-quality options, including some whiskey fans' longtime favorites. Each of these ...

The following NBA betting trends are a collection of analytical data, betting systems and strength ratings featured on VSiN and qualified for the NBA games of Friday, March 14, 2025. This report is ...

In the study cohort, 2,310 patients died during a median follow-up of 6.3 years, and prostate cancer accounted for 454 (19.7% ...

A recent analysis based on samples collected in February has revealed a decline in the Yamuna's water quality, with the river ...

Steve Makinen and the VSiN Analytics team share the NBA betting trends you need to know for Thursday, March 13 ...

The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...

Luckily we spritzed and whiffed several new scents to find the seven best new florals, gourmands and even a second-skin scent ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.

ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...

Ataccama, the data trust company, has been named a Leader in the latest Gartner Magic Quadrant for Augmented Data Quality Solutions. Gartner included ...

Merck's DOR/ISL met primary efficacy and safety goals in two Phase 3 HIV trials. Marketing applications are planned for ...

New data from the MK-8591A-051 and MK-8591A-052 trials, both investigating the efficacy and safety of 100-mg doravirine and 0.25-mg islatravir as a once-daily 2-drug regimen for virologically ...